Clinical Trials Browser

NCT07368634 2026-01-28

Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Phase 1/2 Recruiting

18 enrolled

Epstein-Barr Virus Infections

NCT07358910 2026-01-22

RACSMEI

Recruiting

10,000 enrolled

Classical hematology

Zika Virus Infection, Vaccine-Preventable Diseases, Vector Borne Diseases, Severe Fever with Thrombocytopenia Syndrome, Adenoviridae Infections, Arenaviridae Infections, Brucellosis, Bunyaviridae Infections, Chickenpox, Chlamydia Infections, Communicable Diseases, Dengue, Elephantiasis, Filarial, Encephalitis, Japanese, Encephalitis, Tick-Borne, Enterovirus Infections, Giardiasis, Hepatitis A, Leishmaniasis, Leptospirosis, Malaria, Measles, Melioidosis, Meningitis, Mumps, Mycoplasma Infections, Parvoviridae Infections, Q Fever, Rift Valley Fever, Rotavirus Infections, Rubella, Schistosomiasis, Tetanus, Trichuriasis, Whooping Cough, Yellow Fever, Zoonoses, Hepatitis E, Caliciviridae Infections, Hantavirus Infections, Epstein-Barr Virus Infections, Henipavirus Infections, Neglected Diseases, Chikungunya Fever

Clinical Trials

Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

RACSMEI

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

VSTs

CILESTE

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

TETRAVI

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

TRACE

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

MECFS-R

R-MVST Cells for Treatment of Viral Infections

Deep Learning-based sbORN Diagnostic Model

Evaluation of CMV/EBV-CMI in Haploid HSCT

Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

GI-hNeoT-01

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

MUC-CFS

Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection